Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Precision medicine for cardiometabolic disease: a framework for clinical translation.
Franks PW, Cefalu WT, Dennis J, Florez JC, Mathieu C, Morton RW, Ridderstråle M, Sillesen HH, Stehouwer CDA. Franks PW, et al. Among authors: dennis j. Lancet Diabetes Endocrinol. 2023 Nov;11(11):822-835. doi: 10.1016/S2213-8587(23)00165-1. Epub 2023 Oct 4. Lancet Diabetes Endocrinol. 2023. PMID: 37804856 Review.
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.
Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; symposium planning committee, moderators, and speakers. Cefalu WT, et al. Diabetes. 2021 Nov 15;71(1):1-22. doi: 10.2337/db21-0777. Online ahead of print. Diabetes. 2021. PMID: 34782351 Free PMC article.
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.
Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; Symposium planning committee, moderators, and speakers:; Rosenblum N, Cefalu W, Andersen DK, Arreaza-Rubín G, Dhara C, James SP, Makarchuk MJ, Pin CL, Sato S, Verchere B, Woo M, Powers A, Estall J, Hoesli C, Millman J, Linnemann A, Johnson J, Pin CL, Hawkins M, Woo M, Gloyn A, Cefalu W, Rosenblum N, Huising MO, Benninger RKP, Almaça J, Hull-Meichle RL, MacDonald P, Lynn F, Melero-Martin J, Yoshihara E, Stabler C, Sander M, Evans-Molina C, Engin F, Thompson P, Shalev A, Redondo MJ, Nadeau K, Bellin M, Udler MS, Dennis J, Dash S, Zhou W, Snyder M, Booth G, Butte A, Florez J. Cefalu WT, et al. Among authors: dennis j. Diabetes. 2021 Nov 13:db210777. doi: 10.2337/db21-0777. Online ahead of print. Diabetes. 2021. PMID: 34957490 Review.
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.
Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; Symposium planning committee, moderators, and speakers. Cefalu WT, et al. Diabetes Care. 2022 Jan 1;45(1):3-22. doi: 10.2337/dci21-0051. Diabetes Care. 2022. PMID: 34782355 Free PMC article. Review.
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.
Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; symposium planning committee, moderators, and speakers. Cefalu WT, et al. Can J Diabetes. 2021 Dec;45(8):697-713. doi: 10.1016/j.jcjd.2021.09.126. Epub 2021 Nov 15. Can J Diabetes. 2021. PMID: 34794897
Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review.
Bodhini D, Morton RW, Santhakumar V, Nakabuye M, Pomares-Millan H, Clemmensen C, Fitzpatrick SL, Guasch-Ferre M, Pankow JS, Ried-Larsen M, Franks PW; ADA/EASD PMDI; Tobias DK, Merino J, Mohan V, Loos RJF. Bodhini D, et al. Commun Med (Lond). 2023 Oct 5;3(1):133. doi: 10.1038/s43856-023-00363-0. Commun Med (Lond). 2023. PMID: 37794109 Free PMC article.
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review.
Jacobsen LM, Sherr JL, Considine E, Chen A, Peeling SM, Hulsmans M, Charleer S, Urazbayeva M, Tosur M, Alamarie S, Redondo MJ, Hood KK, Gottlieb PA, Gillard P, Wong JJ, Hirsch IB, Pratley RE, Laffel LM, Mathieu C; ADA/EASD PMDI. Jacobsen LM, et al. Commun Med (Lond). 2023 Oct 5;3(1):132. doi: 10.1038/s43856-023-00358-x. Commun Med (Lond). 2023. PMID: 37794113 Free PMC article.
Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis.
Lim S, Takele WW, Vesco KK, Redman LM, Hannah W, Bonham MP, Chen M, Chivers SC, Fawcett AJ, Grieger JA, Habibi N, Leung GKW, Liu K, Mekonnen EG, Pathirana M, Quinteros A, Taylor R, Ukke GG, Zhou SJ; ADA/EASD PMDI; Josefson J. Lim S, et al. Commun Med (Lond). 2023 Oct 5;3(1):137. doi: 10.1038/s43856-023-00366-x. Commun Med (Lond). 2023. PMID: 37794119 Free PMC article.
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion.
Murphy R, Colclough K, Pollin TI, Ikle JM, Svalastoga P, Maloney KA, Saint-Martin C, Molnes J; ADA/EASD PMDI; Misra S, Aukrust I, de Franco E, Flanagan SE, Njølstad PR, Billings LK, Owen KR, Gloyn AL. Murphy R, et al. Commun Med (Lond). 2023 Oct 5;3(1):136. doi: 10.1038/s43856-023-00369-8. Commun Med (Lond). 2023. PMID: 37794142 Free PMC article.
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review.
Young KG, McInnes EH, Massey RJ, Kahkoska AR, Pilla SJ, Raghavan S, Stanislawski MA, Tobias DK, McGovern AP, Dawed AY, Jones AG, Pearson ER, Dennis JM; ADA/EASD PDMI. Young KG, et al. Among authors: dennis jm. Commun Med (Lond). 2023 Oct 5;3(1):131. doi: 10.1038/s43856-023-00359-w. Commun Med (Lond). 2023. PMID: 37794166 Free PMC article.
1,499 results